Latest development of approved COVID-19 drugs and COVID-19 drugs undergoing late stage clinical trials
As the world adapts to living with SARS-CoV-2, the continuous emergence of new variants has become a primary focus of current studies. In this review, we examined a range of available COVID-19 drugs, including FDA-regulated drugs and those undergoing late-stage clinical trials. Some FDA-regulated dr...
Main Authors: | Bingru Feng, Kai Fu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-12-01
|
Series: | Frontiers in Drug Discovery |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fddsv.2023.1304129/full |
Similar Items
-
Severe COVID-19: Drugs and Clinical Trials
by: Hazael Ramiro Ceja-Gálvez, et al.
Published: (2023-04-01) -
Evaluation of commonly used drugs in patients with COVID-19: A systematic review study
by: Shahab Dastmardi, et al.
Published: (2021-12-01) -
Repurposing of drugs for combined treatment of COVID-19 cytokine storm using machine learning
by: Maanaskumar R. Gantla, et al.
Published: (2023-02-01) -
Use of repurposed drugs in COVID-19 pandemic: Old drugs without new tricks?
by: Suraj Kapoor
Published: (2023-01-01) -
COVID-19 therapeutics: Clinical application of repurposed drugs and futuristic strategies for target-based drug discovery
by: Sunny Kumar, et al.
Published: (2023-07-01)